Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice

Neurobiology of Learning and Memory

Volumn 88, Issue 2, 2007, Pages 217-224

  Dineley, Kelly T ^a   Hogan, Dale ^a   Zhang, Wen Ru ^b   Taglialatela, Giulio ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Amyloid beta; Behavior; Calcineurin; Fear conditioning; FK506; SY5Y cells; Tg2576 mice

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCINEURIN; TACROLIMUS;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG INHIBITION; ENZYME ACTIVATION; FEMALE; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MOUSE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN; PHOSPHORYLATION; SINGLE DRUG DOSE; STUDENT T TEST; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; ASSOCIATION LEARNING; CALCINEURIN; CELL DEATH; COGNITION; CONDITIONING (PSYCHOLOGY); IMMUNOSUPPRESSIVE AGENTS; MEMORY; MICE; MICE, TRANSGENIC; NEURONS; TACROLIMUS;

EID: 34547653708     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2007.03.010     Document Type: Article

References (38)

1. Agostinho P., and Oliveira C.R. Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides. European Journal of Neuroscience 17 (2003) 1189-1196
2. Baran D.A., Galin I.D., and Gass A.L. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: Risk factors and strategies for prevention and treatment. American Journal of Cardiovascular Drugs 4 (2004) 21-29
3. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., and Sharkey J. Neuroprotective actions of FK506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism. Journal of Neuroscience 17 (1997) 6939-6946
4. Chen Q.S., Wei W.Z., Shimahara T., and Xie C.W. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiology of Learning and Memory 77 (2002) 354-371
5. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-protein specifically disrupt cognitive function. Nature Neuroscience 8 (2005) 79-84
6. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nature Neuroscience 8 (2005) 79-84
7. Comery T.A., Martone R.L., Aschmies S., Atchison K.P., Diamantidis G., Gong X., et al. Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease. Journal of Neuroscience 25 (2005) 8898-8902
8. Corcoran K.A., Lu Y., Turner R.S., and Maren S. Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learning & Memory 9 (2002) 243-252
9. Dineley K.T., Xia X., Bui D., Sweatt J.D., and Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. Journal of Biological Chemistry 277 (2002) 22768-22780
10. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., and Sweatt J.D. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. Journal of Neuroscience 21 (2001) 4125-4133
11. Dougherty J.J., Wu J., and Nichols R.A. Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. Journal of Neuroscience 23 (2003) 6740-6747
12. Foster T.C., Sharrow K.M., Masse J.R., Norris C.M., and Kumar A. Calcineurin links Ca2+ dysregulation with brain aging. Journal of Neuroscience 21 (2001) 4066-4073
13. Fukudo M., Yano I., Masuda S., Okuda M., and Inui K. Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity. The Journal of Pharmacology and Experimental Therapeutics 312 (2005) 816-825
14. Glabe C.G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiology of Aging 27 (2006) 570-575
15. Gordon M.N., Holcomb L.A., Jantzen P.T., DiCarlo G., Wilcock D., Boyett K.W., et al. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse. Experimental Neurology 173 (2002) 183-195
16. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
17. Ikegami S., and Inokuchi K. Antisense DNA against calcineurin facilitates memory in contextual fear conditioning by lowering the threshold for hippocampal long-term potentiation induction. Neuroscience 98 (2000) 637-646
18. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., and Hyman B.T. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. Journal of Neuropathology and Experimental Neurology 56 (1997) 965-973
19. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. Journal of Neuroscience 21 (2001) 372-381
20. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
21. Lin C.H., Lee C.C., and Gean P.W. Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Molecular Pharmacology 63 (2003) 44-52
22. Lin C.H., Yeh S.H., Leu T.H., Chang W.C., Wang S.T., and Gean P.W. Identification of calcineurin as a key signal in the extinction of fear memory. Journal of Neuroscience 23 (2003) 1574-1579
23. Malleret G., Haditsch U., Genoux D., Jones M.W., Bliss T.V., Vanhoose A.M., et al. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104 (2001) 675-686
24. Mansuy I.M. Calcineurin in memory and bidirectional plasticity. Biochemical and Biophysical Research Communications 311 (2003) 1195-1208
25. Mansuy I.M., and Shenolikar S. Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory. Trends in Neuroscience 29 (2006) 679-686
26. Maren S., Aharonov G., and Fanselow M.S. Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: Absence of a temporal gradient. Behavioral Neuroscience 110 (1996) 718-726
27. Norris C.M., Kadish I., Blalock E.M., Chen K.C., Thibault V., Porter N.M., et al. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. Journal of Neuroscience 25 (2005) 4649-4658
28. Olyaei A.J., de Mattos A.M., and Bennett W.M. Nephrotoxicity of immunosuppressive drugs: New insight and preventive strategies. Current Opinion in Critical Care 7 (2001) 384-389
29. Selkoe D.J. Defining molecular targets to prevent Alzheimer disease. Archives of Neurology 62 (2005) 192-195
30. Selkoe D.J., and Schenk D. Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics. Annual Review of Pharmacology and Toxicology 43 (2003) 545-584
31. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nature Neuroscience 8 (2005) 1051-1058
32. Springer J.E., Azbill R.D., Nottingham S.A., and Kennedy S.E. Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. Journal of Neuroscience 20 (2000) 7246-7251
33. Staatz C.E., and Tett S.E. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clinical Pharmacokinetics 43 (2004) 623-653
34. Takeuchi A., Irizarry M.C., Duff K., Saido T.C., Hsiao Ashe K., Hasegawa M., et al. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. American Journal of Pathology 157 (2000) 331-339
35. Van Gassen G., and Annaert W. Amyloid, presenilins, and Alzheimer's disease. The Neuroscientist 9 (2003) 117-126
36. Wang H.G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284 (1999) 339-343
37. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. Journal of Neuroscience 22 (2002) 1858-1867
38. Zeng H., Chattarji S., Barbarosie M., Rondi-Reig L., Philpot B.D., Miyakawa T., et al. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107 (2001) 617-629